Non-coding RNAs in breast cancer: intracellular and intercellular communication

CM Klinge - Non-coding RNA, 2018 - mdpi.com
Non-coding RNAs (ncRNAs) are regulators of intracellular and intercellular signaling in
breast cancer. ncRNAs modulate intracellular signaling to control diverse cellular processes …

MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment

PJ Kaboli, A Rahmat, P Ismail, KH Ling - Pharmacological research, 2015 - Elsevier
Abstract MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …

LGR5 promotes breast cancer progression and maintains stem-like cells through activation of Wnt/β-catenin signaling

L Yang, H Tang, Y Kong, X Xie, J Chen, C Song… - Stem …, 2015 - academic.oup.com
The cancer stem cell (CSC) hypothesis suggests that a subset of cancer cells possesses
stem cell properties and is crucial in tumor initiation, metastasis, and drug resistance. To …

Epigenetic modification regulates tumor progression and metastasis through EMT

T Tan, P Shi, MN Abbas, Y Wang… - International …, 2022 - spandidos-publications.com
Epigenetics is the study of heritable molecular determinants that are independent of
phenotypic features. The epigenetic features include DNA methylation, histone …

Mouse models of breast cancer in preclinical research

MK Park, CH Lee, H Lee - Laboratory animal research, 2018 - Springer
Breast cancer remains the second leading cause of cancer death among woman,
worldwide, despite advances in identifying novel targeted therapies and the development of …

[HTML][HTML] miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies

N Amodio, M Rossi, L Raimondi, MR Pitari, C Botta… - Oncotarget, 2015 - ncbi.nlm.nih.gov
A wealth of studies has highlighted the biological complexity of hematologic malignancies
and the role of dysregulated signal transduction pathways. Along with the crucial role of …

Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction

D Kashyap, H Kaur - Life sciences, 2020 - Elsevier
Breast cancer is one of the genetic diseases causing a high mortality among women around
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …

[HTML][HTML] Nanomaterial-assisted CRISPR gene-engineering–A hallmark for triple-negative breast cancer therapeutics advancement

J Farheen, NS Hosmane, R Zhao, Q Zhao, MZ Iqbal… - Materials Today Bio, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is the most violent class of tumor and accounts for 20–
24% of total breast carcinoma, in which frequently rare mutation occurs in high frequency …

[HTML][HTML] miR-200c inhibits breast cancer proliferation by targeting KRAS

C Song, LZ Liu, XQ Pei, X Liu, L Yang, F Ye, X Xie… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract The microRNA, miR-200c, is involved in the tumorigenesis and progression of a
variety of cancers. The purpose of this study was to investigate the expression, mechanism …

MicroRNAs: diverse mechanisms of action and their potential applications as cancer epi-therapeutics

A Sadakierska-Chudy - Biomolecules, 2020 - mdpi.com
Usually, miRNAs function post-transcriptionally, by base-pairing with the 3′ UTR of target
mRNAs, repressing protein synthesis in the cytoplasm. Furthermore, other regions including …